Position in GLAS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$520,000
New position
Shares Held
40,000
first reported quarter
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 53 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Pathstone Holdings, LLC holds $42,015,720 across 17 Drug Manufacturers - Specialty & Generic names. GLAS ranks #14 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
273,446 | $6,729,505 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
177,906 | $6,027,454 | |
| 3 | ZTS |
Zoetis Inc.
|
74,081 | $5,323,460 | |
| 4 | ALKS |
Alkermes plc.
|
82,327 | $4,313,934 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
239,306 | $3,836,074 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
5,129 | $2,779,045 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
70,526 | $2,445,136 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
13,005 | $2,191,862 |
All Filings in GLAS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $520,000 | 40,000 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||